$5 for all GeneXpert tests!

Danaher shareholders join the campaign

Danaher shareholders worth over $400 billion in assets called on Danaher to audit and disclose the cost of production for the GeneXpert test cartridges and adjust their prices accordingly to ensure access to these lifesaving tests. In a letter to Danaher, they said, “Such audits are critical to ensure that Danaher is not making profits on the sales of these life-saving tests and remains committed to optimal healthcare access for people living in low and middle-income countries.”

The 'Time for $5' coalition is coordinated by MSF Access Campaign, Partners in Health and Treatment Action Group (TAG), together with more than 150 civil society organizations working to improve access to GeneXpert instruments and tests.

Since 2019, we have been calling on Cepheid and Danaher to lower the price of GeneXpert tests to $5 per test for all diseases. Learn more about the Time for $5 campaign here.